| 1 | MRD30, ZMYND11
|
| A de novo mutation in ZMYND11, a candidate gene for 10p15.3 deletion syndrome, is associated with syndromic intellectual disability.
|
| Cobben JM, Weiss MM, van Dijk FS, De Reuver R, de Kruiff C, Pondaag W, Hennekam RC, Yntema HG.
|
| Eur J Med Genet 57(11-12):636-8. doi: 10.1016/j.ejmg.2014.09.002. Epub 2014 Sep 30.
2014
|
| 2 | ZMYND11
|
| BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing.
|
| Guo R, Zheng L, Park JW, Lv R, Chen H, Jiao F, Xu W, Mu S, Wen H, Qiu J, Wang Z, Yang P, Wu F, Hui J, Fu X, Shi X, Shi YG, Xing Y, Lan F, Shi Y.
|
| Mol Cell 56(2):298-310. doi: 10.1016/j.molcel.2014.08.022. Epub 2014 Sep 25.
2014
|
| 3 | ZMYND11
|
| ZMYND11: an H3.3-specific reader of H3K36me3.
|
| Wen H, Li Y, Li H, Shi X.
|
| Cell Cycle 13(14):2153-4. doi: 10.4161/cc.29732. Epub 2014 Jun 25. No abstract available.
2014
|
| 4 | ZMYND11
|
| ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression.
|
| Wen H, Li Y, Xi Y, Jiang S, Stratton S, Peng D, Tanaka K, Ren Y, Xia Z, Wu J, Li B, Barton MC, Li W, Li H, Shi X.
|
| Nature 508(7495):263-8. doi: 10.1038/nature13045. Epub 2014 Mar 2.
2014
|
| 5 | MAGEC2, ZMYND11
|
| Cancer-testis antigen HCA587/MAGE-C2 interacts with BS69 and promotes its degradation in the ubiquitin-proteasome pathway.
|
| Hao J, Shen R, Li Y, Zhang Y, Yin Y.
|
| Biochem Biophys Res Commun 449(4):386-91. doi: 10.1016/j.bbrc.2014.05.078. Epub 2014 May 24. 2014
|
| 6 | ZMYND11
|
| Crystal structure of human BS69 Bromo-ZnF-PWWP reveals its role in H3K36me3 nucleosome binding.
|
| Wang J, Qin S, Li F, Li S, Zhang W, Peng J, Zhang Z, Gong Q, Wu J, Shi Y.
|
| Cell Res 24(7):890-3. doi: 10.1038/cr.2014.38. Epub 2014 Mar 28. No abstract available.
2014
|
| 7 | DEAF1, NCOR1, NCOR2, ZMYND11
|
| Structural and functional analysis of the DEAF-1 and BS69 MYND domains.
|
| Kateb F, Perrin H, Tripsianes K, Zou P, Spadaccini R, Bottomley M, Franzmann TM, Buchner J, Ansieau S, Sattler M.
|
| PLoS One 8(1):e54715. doi: 10.1371/journal.pone.0054715. Epub 2013 Jan 25.
2013
|
| 8 | DEL10PT, DIP2C, ZMYND11
|
| Subtelomeric deletion of chromosome 10p15.3: Clinical findings and molecular cytogenetic characterization.
|
| Descipio C, Conlin L, Rosenfeld J, Tepperberg J, Pasion R, Patel A, McDonald MT, Aradhya S, Ho D, Goldstein J, McGuire M, Mulchandani S, Medne L, Rupps R, Serrano AH, Thorland EC, Tsai AC, Hilhorst-Hofstee Y, Ruivenkamp CA, Van Esch H, Addor MC, Martinet D, Mason TB, Clark D, Spinner NB, Krantz ID.
|
| Am J Med Genet A 158A(9):2152-61. doi: 10.1002/ajmg.a.35574. Epub 2012 Jul 27. 2012
|
| 9 | LTBR, ZMYND11
|
| The MYND domain-containing protein BRAM1 inhibits lymphotoxin beta receptor-mediated signaling through affecting receptor oligomerization.
|
| Liu HP, Chung PJ, Liang CL, Chang YS.
|
| Cell Signal 23(1):80-8. doi: 10.1016/j.cellsig.2010.08.006. Epub 2010 Aug 21.
2011
|
| 10 | TRAF3, ZMYND11
|
| BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation.
|
| Ikeda O, Miyasaka Y, Yoshida R, Mizushima A, Oritani K, Sekine Y, Kuroda M, Yasui T, Fujimuro M, Muromoto R, Nanbo A, Matsuda T.
|
| FEBS Lett 584(5):865-72. doi: 10.1016/j.febslet.2010.01.060. Epub 2010 Feb 5.
2010
|
| 11 | TICAM1, ZMYND11
|
| Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction.
|
| Takaki H, Oshiumi H, Sasai M, Kawanishi T, Matsumoto M, Seya T.
|
| Eur J Immunol 39(12):3469-76.PMID: 19795416 2009
|
| 12 | PIAS1, UBE2I, ZMYND11
|
| BS69 undergoes SUMO modification and plays an inhibitory role in muscle and neuronal differentiation.
|
| Yu B, Shao Y, Zhang C, Chen Y, Zhong Q, Zhang J, Yang H, Zhang W, Wan J.
|
| Exp Cell Res 315(20):3543-53. doi: 10.1016/j.yexcr.2009.09.011. Epub 2009 Sep 18.
2009
|
| 13 | ZMYND11
|
| BS69 is involved in cellular senescence through the p53-p21Cip1 pathway.
|
| Zhang W, Chan HM, Gao Y, Poon R, Wu Z.
|
| EMBO Rep 8(10):952-8. Epub 2007 Aug 24. 2007
|
| 14 | ZMYND11
|
| New insights into BS69 functions.
|
| Velasco G, Grkovic S, Ansieau S.
|
| J Biol Chem 281(24):16546-50. Epub 2006 Mar 24. 2006
|
| 15 | ZMYND11
|
| BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway.
|
| Wan J, Zhang W, Wu L, Bai T, Zhang M, Lo KW, Chui YL, Cui Y, Tao Q, Yamamoto M, Akira S, Wu Z.
|
| Mol Cell Biol 26(2):448-56. 2006
|
| 16 | ZMYND11
|
| Ubiquitin-dependent degradation of adenovirus E1A protein is inhibited by BS69.
|
| Isobe T, Uchida C, Hattori T, Kitagawa K, Oda T, Kitagawa M.
|
| Biochem Biophys Res Commun 339(1):367-74. Epub 2005 Nov 14. 2006
|
| 17 | CHAMP1, CYP2E1, DIP2C, DOC2B, FOXD4, FRG1, GAS8, RIC8A, SDHA, TRIM7, ZMYND11
|
| Telomere length and the expression of natural telomeric genes in human fibroblasts.
|
| Ning Y, Xu JF, Li Y, Chavez L, Riethman HC, Lansdorp PM, Weng NP.
|
| Hum Mol Genet 12(11):1329-36. 2003
|
| 18 | ETS2, ZMYND11
|
| Ets-2 interacts with co-repressor BS69 to repress target gene expression.
|
| Wei G, Schaffner AE, Baker KM, Mansky KC, Ostrowski MC.
|
| Anticancer Res 23(3A):2173-8. 2003
|
| 19 | ZMYND11
|
| The adenovirus E1A binding protein BS69 is a corepressor of transcription through recruitment of N-CoR.
|
| Masselink H, Bernards R.
|
| Oncogene 19(12):1538-46. 2000
|
| 20 | ZMYND11
|
| BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation.
|
| Hateboer G, Gennissen A, Ramos YF, Kerkhoven RM, Sonntag-Buck V,Stunnenberg HG, Bernards R.
|
| EMBO J 14(13):3159-69. 1995
|